Cover Image
市場調查報告書

核心實驗室診斷:競爭情形的調查

Core Laboratory Diagnostics: Surveying the Competitive Landscape

出版商 Espicom Business Intelligence 商品編碼 372001
出版日期 內容資訊 英文 129 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
核心實驗室診斷:競爭情形的調查 Core Laboratory Diagnostics: Surveying the Competitive Landscape
出版日期: 2016年03月01日 內容資訊: 英文 129 Pages
簡介

核心實驗室診斷市場構成IVD (體外診斷) 整體市場的約60%,從2013年到2014年的成長率表現約為4.8%急速成長。

本報告提供全球核心實驗室診斷市場上短期、中期性的市場展望調查,競爭情形評估,市場展望,各企業的市場佔有率,產業整合的影響,M&A活動,法規、醫療費償付環境,地區性的機會,推動成長因素、抑制因素,以及未來的機會等系統性資訊。

摘要整理

  • 背景
  • 市場概要
    • 產品區分
      • 免疫化學
      • 血液學
      • 尿液檢查
      • 臨床化學
      • 止血
      • IT、自動化系統
    • 地區展望
    • 競爭情形
      • 產業整合
  • 法規、醫療費償付環境
    • 歐洲
    • 美國
  • 推動成長因素、抑制因素、未來的機會
  • 市場展望

在市場活動的主要企業

  • ABBOTT
  • BECTON DICKINSON AND COMPANY
  • BECKMAN COULTER
  • BIOMERIEUX
  • BIO-RAD LABORATORIES
  • DIASORIN
  • HORIBA 醫學
  • IMMUCOR
  • MERIDIAN BIOSCIENCE
  • ORTHO-CLINICAL DIAGNOSTICS
  • ROCHE
  • SEKISUI DIAGNOSTICS
  • SIEMENS HEALTHCARE
  • SYSMEX
  • THERMO FISHER SCIENTIFIC
  • Tosoh生物科學產業部

附錄

目錄

The core laboratory diagnostics market accounts for approximately 60% of the total IVD Market and is growing fast, at a rate of around 4.8% (2013-2014).

‘Core Laboratory Diagnostics - Surveying the Competitive Landscape ’ examines the global market outlook in the short and mid-term and assesses the competitive landscape - market oulook, market share by company, the effect of industry consolidation, M&A activity, regulatory and reimbursement environment, regional opportunities, growth drivers, restraints and future opportunities.

The point of care sector is currently seeing high levels of growth due to increasing adoption of POC technologies and rising demand in emerging markets. With such a wide range of products being encompassed, it's essential to be on top of the latest developments as they happen and understand the trends shaping the sector's operation. Espicom provides all this with its series of in-depth analysis reports and news services.

The ‘Core Laboratory Diagnostics - Surveying the Competitive Landscape ’ Report, published April 2016, provides a timely overview of the huge potential of this growth market, with details of all the key products to consider and competitive intelligence on companies active in the sector.

The report includes a market overview of main product segments:

  • Immunochemistry
  • Haemostasis
  • Haemotology
  • Urinalysis
  • Clinical Chemistry
  • IT and Automation systems

‘Core Laboratory Diagnostics - Surveying the Competitive Landscape ’ examines the global market outlook in the short and mid-term and assesses the competitive landscape - market oulook, market share by company, the effect of industry consolidation, M&A activity, regulatory and reimbursement environment, regional opportunities, growth drivers, restraints and future opportunities.

The report includes 16 profiles of major companies:

Abbott, Becton Dickinson, Beckman Coulter, Biomerieux, Bio-Rad Laboratories, Diasorin, Horiba Medical, Immucor, Meridian Bioscience, Ortho-Clinical Diagnostics, Roche, Sekisui, Siemens Healthcare, Sysmex, Thermo Fisher Scientific and Tosoh Bioscience.

Each profile contains:

  • Key product offerings
  • Alliances and Agreements
  • Financial Performance
  • Latest Results
  • Recent Key Events

Published by BMI Research - experts in the pharmaceutical, medical devices and healthcare field for over 30 years, the ‘Core Laboratory Diagnostics - Surveying the Competitive Landscape ’ Report brings together a range of often difficult to source information in one single, convenient and comprehensive publication.

Table of Contents

EXECUTIVE SUMMARY

  • BACKGROUND
  • MARKET OVERVIEW
    • Product Segments
      • Immunochemistry
      • Haematology
      • Urinalysis
      • Clinical Chemistry
      • Haemostasis
      • IT and Automation Systems
    • Regional Perspective
    • Competitive Landscape
      • Industry Consolidation
  • REGULATORY AND REIMBURSEMENT ENVIRONMENT
    • Europe
    • United States
      • CLIA ‘88
  • GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES
  • MARKET OUTLOOK

MAJOR COMPANIES ACTIVE IN THE MARKET

  • ABBOTT
    • Key Products
      • Immunochemistry Products
        • Assays
      • Haematology
      • Transfusion Products
      • Automation Products
    • Alliances and Agreements
      • Sekisui
      • BG Medicine
    • Financial Performance
      • Latest Results
  • BECTON DICKINSON AND COMPANY
    • Key Products
      • Direct Testing and Serology
        • BD Veritor System
      • BD BACTEC Blood Culture Systems
      • BD FACSPresto Near-Patient CD4 Counter
      • Mycobacteria Testing
      • Women's Health Screening
    • Financial Performance
  • BECKMAN COULTER
    • Key Products
      • Immunoassay Systems
        • Access 2 Immunoassay System
        • UniCel DxI Immunoassay Systems
        • Recently-launched Assays
      • Clinical Chemistry and Immunochemistry Systems
        • Cystatin C Assay
        • HbA1c Assay
      • Haematology Analysers
        • DxH Series
        • UniCel DxH 600 Coulter
        • Alifax Automated Erythrocyte Sedimentation Rate Analysis System
        • COULTER AC•T Analysers
    • Automated Sample Processing System
      • Power Express Automated Sample Processing System
    • Clinical Flow Cytometry
      • AQUIOS CL Flow Cytometer
    • MicroScan Microbiology Portfolio
    • Rapid Tests
      • Hemoccult Tests
      • Gastroccult
    • Agreements
      • COPAN
      • DiaSorin
      • Bio-Rad Laboratories
      • Thermo Fisher Scientific
      • Canterbury Scientific
      • hc1.com
      • Alifax
      • Atonomics
    • Financial Performance

BIOMÉRIEUX

  • Key Products
    • VIDAS Automated Laboratory Immunoassay Systems
      • VIDAS 3
      • VIDAS C. difficile GDH
      • VIDAS 25 OH Vitamin D Total
    • Clinical Microbiology
      • chromID Culture Media
      • Blood Culture Systems
      • RAPIDEC CARBA NP Test
      • UF-1000i & UF-500i Urinary Screening Systems
    • Agreements
      • Astute Medical
      • Thermo Fisher Scientific
      • Roche
    • Financial Performance
      • Latest Results

BIO-RAD LABORATORIES

  • Key Products
    • Immunohaematology Products
      • TANGO infinity
      • IH-500
    • Diabetes Testing
      • D-100 System
      • VARIANT II TURBO HbA1c Kit - 2.0
    • BioPlex 2200 System
      • BioPlex 2200 HIV Ag-Ab
      • BioPlex 2200 25-OH Vitamin D
    • Blood Virus Testing
      • Geenius HIV 1/2 Supplemental Assay
    • Autoimmune Testing
    • Microbiology
    • BRiCare System
    • Agreements
      • Beckman Coulter
    • Financial Performance
      • Latest Results

DIASORIN

  • Product Highlights
    • LIAISON Chemiluminescent Immunoassay Immunodiagnostic Analysers
      • LIAISON XL
      • LIAISON
    • LIAISON CLIA Assays
      • Stool Panel Tests
      • LIAISON Calprotectin Test
      • LIAISON BRAHMS PCT II GENERATION Assay
      • Bordetella Pertussis Tests
      • 1,25 Dihydroxyvitamin D Test
      • LIAISON XL murex HIV Ab/Ag High Throughput (HT)
      • LIAISON N-TACT PTH Gen II Assay
      • LIAISON XL Hepatitis, Retrovirus and Syphilis Tests
      • LIAISON XL Chagas Test
      • LIAISON Fertility Panel
      • LIAISON Chlamydia Trachomatis IgG and IgA Assays
      • LIAISON Aldosterone Assay
    • ELSIA Analysers
      • Freedom EVOlyzer 2-150/8
      • ETI-MAX 3000
    • Agreements
      • Beckman Coulter
      • B•R•A•H•M•S
      • Roche
      • Laboratory Corporation of America
    • Financial Performance
      • Latest Results

HORIBA MEDICAL

  • Key Products
    • Haematology Analysers
      • EasyCell
      • Pentra Nexus
      • Pentra XLR
      • ABX Micros ES60
      • ABX Micros CRP 200
      • ABX E-Sat
      • ABX Pentra 60C+
    • Clinical Chemistry Analysers
      • ABX Pentra 400 Clinical Chemistry Analyser
      • Pentra C200
  • Agreements
    • NoemaLife
    • Medica
  • Financial Performance
    • Latest Results

IMMUCOR

  • Key Products
    • Transfusion Product Portfolio
      • Echo Immunohaematology Automation System
      • Neo Immunohaematology Automation System
      • Capture Workstation
      • Capture Products
      • ImmuLINK Software
      • Other Products
    • Transplant Product Portfolio
    • LIFECODES Haemostasis Products
  • Mergers and Acquisitions
    • Sentilus
    • Organ-i
    • LIFECODES

MERIDIAN BIOSCIENCE

  • Key Products
    • Rapid Tests
      • TRU STREP PNEUMO
      • TRU FLU and TRU RSV
      • C.difficile Tests
      • ImmunoCard STAT! HpSA H. pylori Test
      • ImmunoCard STAT! Rotavirus
      • ImmunoCard STAT! Strep A
      • ImmunoCard STAT! MONO
      • ImmunoCard STAT! hCG Combo Test
    • Para-Pak SVT
  • Strategic Alliance with Oasis Diagnostics
  • Financial Performance

ORTHO-CLINICAL DIAGNOSTICS

  • Key Products
    • Clinical Laboratory Products
      • VITROS 4600 Chemistry System
      • VITROS 350 Chemistry System
      • Astute Medical's NephroCheck Test and Astute140 Meter
      • Clinical Study Results
      • Immunodiagnostics
      • VITROS 5600 Integrated System
    • Transfusion Medicine
      • Donor Screening
      • Immunohaematology
  • Agreements
    • Quotient
    • Astute Medical

ROCHE

  • Key Products
    • Diabetes
      • cobas c 513
    • cobas Clinical Chemistry and Immunochemistry Analysers
    • cobas Clinical Chemistry and Immunochemistry Assays
      • Elecsys Immunosuppressive Drug (ISD) Assays
      • Elecsys HTLV-I/II
      • Elecsys Preeclampsia Test
      • TDM Methotrexate cobas c Test Kits
      • Elecsys Anti-Müllerian Hormone
      • Elecsys Syphilis
      • Tina-quant HbA1cDx Gen. 2 Assay
      • Elecsys ProGRP
      • Elecsys Calcitonin
    • Urinalysis
      • cobas 6500
    • Haemostasis Systems and Tests
      • cobas t
    • IT and Automation Solutions
      • cobas infinity
      • cobas 8100 Automated Workflow Solution
      • cobas IT middleware
      • cobas connection modules
      • cobas Pre-Analytical Systems
    • Alliances and Contracts
      • ARK Diagnostics
      • Ferring Pharmaceuticals
      • Hitachi High-Technologies Corporation
      • DiaSorin
      • BioMérieux
      • Alere
      • Siemens
    • Financial Performance
      • Latest Results

SEKISUI DIAGNOSTICS

  • Key Products
    • Rapid Tests
      • OSOM Ultra Flu A&B Test
      • OSOM Ultra hCG Combo Test
      • OSOM iFOB Test
      • OSOM C. difficile Toxin A/B Test
      • OSOM Influenza A & B Test
      • OSOM H. pylori
      • OSOM Ultra Strep A
      • OSOM Strep A
      • OSOM Mono
      • OSOM Trichomonas Rapid Test
      • OSOM BVBLUE Test
      • OSOM ImmunoDip Urinary Albumin Test
      • OSOM Pregnancy Tests
    • Clinical Chemistry
      • SK500 Chemistry System
      • Coapresta 2000 (CP2000) Coagulation System
    • Alliance with Abbott

SIEMENS HEALTHCARE

  • Key Products
    • Immunoassay Products
    • Clinical Chemistry Systems
      • ADVIA Chemistry XPT System
      • ADVIA 2400 Clinical Chemistry System
      • ADVIA 1800 Clinical Chemistry System
    • Haematology Systems
    • Haemostasis
      • INNOVANCE Heparin Assay
    • Integrated Chemistry
    • New Chemistry Assays
      • IMMULITE TSI Assay
      • Advia Centaur Vitamin D Total Assay
    • Urinalysis
      • Clinitek Status+
      • Clinitek Novus
      • Clinitek Atlas
      • Clinitek AUWi
      • Clinitek Advantus
      • Clinitek Status Connect
      • Multistix10 SG Reagent Strips
      • Clinitek Microalbumin Strips
      • Clinitest hCG Pregnancy Test
      • Drug Testing Diagnostics
    • Infectious Disease Testing
      • Enzygnost HIV Integral 4 Assay
    • Plasma Protein Systems
      • BN ProSpec i
      • BN II System
    • Laboratory Automation
      • Aptio Automation
      • VersaCell X3 Solution
  • Current Alliances and Supply Contracts
    • KreLo GmbH Medical Diagnostics
    • CANCER-ID Consortium
    • Pfizer
    • Sysmex
    • Roche
    • Financial Performance
      • Latest Results

SYSMEX

  • Key Products
    • Urinalysis
      • UC-3500
      • UF-5000/4000/3000
    • Haemostasis
      • CS-1600 Automated Blood Coagulation Analyzer
      • CS-2400/2500 Analsyers
      • Platelet Aggregation Agonist Reagent Kits
      • LIASAUTO P-FDP Haemostasis Reagent
    • Haematology
      • XN-L Series
    • Sysmex HISCL-Series Automated Immunoassay Systems
      • HISCL-800 Automated Immunoassay System
      • HISCL M2BPGi Assay Kit
      • HISCL TARC Assay Kit (HISCL TARC1)
    • Sysmex WAM
  • Manufacturing Operations
  • Alliances
    • Eiken Chemical Co Ltd
    • Shionogi
    • Siemens
  • Financial Performance
    • Latest Results

THERMO FISHER SCIENTIFIC

  • Key Products
    • Clinical Diagnostics
      • New Allergy and Autoimmunity Testing Products
      • Phadia Laboratory Systems
      • Immunoassay Products
    • Microbiology
    • Anatomical Pathology
    • Transplant Diagnostics
    • Healthcare Market Channel Products
      • Sure-Vue Tests
      • Remel's Xpect Tests
  • Alliances and Contracts
    • Beckman Coulter
    • bioMérieux
    • Financial Performance
    • Latest Results

TOSOH BIOSCIENCE

  • Key Products
    • AIA Immunoassay Analysers
    • AIA Assays
      • ST AIA-PACK SHBG
      • ST AIA-PACK PIVKA II
      • ST AIA-PACK SCC
      • ST AIA-PACK Free PSA
      • ST AIA-PACK 25-OH Vitamin D
    • HLC-729LP II Lipoprotein Analyser
    • Tosoh G8 (Tosoh Automated Glycohemoglobin Analyzer HLC-723G8)

APPENDICES

  • APPENDIX 1 - LIST OF ABBREVIATIONS
  • APPENDIX 2 - REPORT METHODOLOGY
    • Market Forecasts

LIST OF TABLES

  • Global Core Laboratory Diagnostics Market by Product Type, 2013-2014 (US$ million)
  • Summary: Market Drivers, Restraints and Opportunities
  • Core Laboratory Diagnostics Market: Forecasts by Product Type, 2014-2020E (US$ million)
  • Core Laboratory Diagnostics Market: Forecast Product Growth, 2014-2020E (%)
  • Abbott Diagnostics - Revenue by Region, 2013-2014 (US$ millions)
  • Abbott Diagnostics - Core Laboratory Revenue by Region, 2013-2014 (US$ millions)
  • Recent Key Events
  • Recent Key Events
  • Recent Key Events
  • bioMérieux - Operating Results, 2012-2014 (EUR millions)
  • Recent Key Events
  • Bio-Rad - Operating Results, 2010-2014 (US$ millions)
  • Bio-Rad - Clinical Diagnostics Division's Operating Results, 2012-2014 (US$ millions)
  • Recent Key Events
  • DiaSorin - Operating Results, 2012-2014 (US$ millions)
  • DiaSorin - Sales by Region, 2013-2014 (US$ millions)
  • Recent Key Events
  • Horiba Medical - Operating Results, 2013-2014 (¥ million)
  • Recent Key Events
  • Recent Key Events
  • Meridian Bioscience - Diagnostics Division Sales by Product Type, 2013-2015 (US$ million)
  • Recent Key Events
  • Recent Key Events
  • Roche Diagnostics: Operating Results, 2010-2014 (SFr million)
  • Recent Key Events
  • Recent Key Events
  • Siemens Healthcare: Operating Results, Fiscal 2014-2015 (EUR million)
  • Recent Key Events
  • Sysmex: Operating Results, Fiscal 2014-2015 (¥ million)
  • Recent Key Events
  • Thermo Fisher Scientific Specialty Diagnostics: Operating Results, 2014-2015 (US$ million)
  • Recent Key Events

LIST OF CHARTS

  • Fig.1: Core Laboratory Diagnostics in Relation to the IVD Market, 2014
  • Fig.2: Percentage of Core Laboratory Diagnostics Market by Product Type, 2014
  • Fig.3: Core Laboratory Diagnostics Market by Region, 2014
  • Fig.4: IVD Diagnostics Market Share by Company, 2014
  • Fig:5: Percentage of Core Laboratory Diagnostics Market by Product, 2020E
  • Fig.6: Abbott Diagnostics - Percentage of Revenue by Product Segment, 2014
  • Fig.7: Abbott - Percentage of Core Laboratory Revenue by Region, 2014
  • Fig.8: BD Diagnostics: Revenue, Y/E 30th September 2011-2015 (US$ millions)
  • Fig.9: Beckman Coulter Diagnostics - Percentage of Revenue by Product Mix, 2014
  • Fig.10: Beckman Coulter Diagnostics - Percentage of Revenue by Region, 2014
  • Fig.11: Beckman Coulter Diagnostics - Percentage of High Growth Markets Revenue by Region, 2014
  • Fig.12: bioMérieux - Percentage of Revenue by Region, 2014
  • Fig.13: bioMérieux - Percentage of Revenue by Product Segment, 2014
  • Fig.14: Bio-Rad - Percentage of Revenue by Product Segment, 2014
  • Fig.15: Bio-Rad - Percentage of Revenue by Region, 2014
  • Fig.16: DiaSorin: LIAISON Immunodiagnostic Analyser Installed Base, 2009-2014
  • Fig.17: DiaSorin - Percentage of Revenue by Region, 2014
  • Fig.18: DiaSorin - Percentage of Revenue by Product Type, 2014
  • Fig.19: Percentage of Horiba's Revenue by Division, 2014
  • Fig.20: Horiba Medical: External Revenue, 2006-2014 (¥ millions)
  • Fig.21: Meridian Bioscience - Revenue by Segment, Fiscal 2015
  • Fig.22: Meridian Bioscience - Diagnostics Sales by Product Type, Fiscal 2015
  • Fig.23: Meridian Bioscience - Diagnostics Sales by Region, Fiscal 2015
  • Fig.24: Ortho-Clinical Diagnostics: Sales by Region, 2009-2013
  • Fig.25: Roche Diagnostics - Percentage of Revenue by Product Segment, 2014
  • Fig.26: Roche Diagnostics - Sales of Immunodiagnostic Tests, 2010-2014 (SFr million)
  • Fig.27: Roche Professional Diagnostics - Percentage of Revenue by Region, 2014
  • Fig.28: Sysmex - Percentage of Revenue by Product Type, Fiscal 2015
  • Fig.29: Sysmex - Percentage of Revenue by Region, Fiscal 2015
  • Fig.30: Thermo Fisher Scientific - Percentage of Revenue by Product Segment, 2014
  • Fig.31: Thermo Fisher Scientific Specialty Diagnostics - Revenue by Product Segment, Q1 2015
  • Fig.32: Thermo Fisher Scientific Specialty Diagnostics - Revenue by Product Type, Q1 2015
  • Fig.33: Thermo Fisher Scientific Specialty Diagnostics - Revenue by Region, Q1 2015
Back to Top